miR-29a-3p mitigates the development of osteosarcoma through modulating IGF1 mediated PI3k/Akt/FOXO3 pathway by

Song Qi1, Li Xu1, Yongyuan Han2

  • 1Department of Trauma Surgery, Wuhan No 1 Hospital, Wuhan, Hubei, China.

Insights

MicroRNA-29a-3p (miR-29a-3p) is downregulated in osteosarcoma (OS). Restoring miR-29a-3p inhibits OS cell growth and metastasis by promoting autophagy and suppressing the IGF1 signaling pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteosarcoma (OS) is a highly malignant bone tumor common in children and adolescents.
  • Understanding the molecular mechanisms regulating OS development is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the expression and functional role of microRNA-29a-3p (miR-29a-3p) in osteosarcoma (OS).
  • To elucidate the relationship between miR-29a-3p and Insulin-like Growth Factor 1 (IGF1) in OS progression.

Main Methods:

  • Reverse transcription-polymerase chain reaction (RT-PCR) for gene expression analysis.
  • Cell proliferation, apoptosis, migration, and invasion assays (MTT, colony formation, Transwell).
  • Dual-luciferase reporter assay and Western blot to confirm molecular interactions and pathway activation.

Main Results:

  • miR-29a-3p was significantly downregulated in OS tissues and cell lines.
  • Overexpression of miR-29a-3p suppressed OS cell proliferation, migration, invasion, and colony formation, while promoting apoptosis and autophagy.
  • IGF1 was identified as a direct target of miR-29a-3p, and IGF1 promoted OS progression via the IGF-1R/PI3k/Akt/FOXO3 pathway.

Conclusions:

  • miR-29a-3p acts as a tumor suppressor in OS by inhibiting cell proliferation, migration, and invasion.
  • miR-29a-3p represses OS development by inducing autophagy and suppressing the IGF1-mediated PI3k/Akt/FOXO3 pathway.
  • Targeting miR-29a-3p or the IGF1 pathway may offer therapeutic strategies for osteosarcoma.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K